ABSTRACT
Glutamatergic neurotransmission system dysregulation may play an important role in the pathophysiology of Alzheimer's disease (AD). However, reported results on glutamatergic components across brain regions are contradictory. Here, we conducted a systematic review with meta-analysis to examine whether there are consistent glutamatergic abnormalities in the human AD brain. We searched PubMed and Web of Science (database origin-October 2023) reports evaluating glutamate, glutamine, glutaminase, glutamine synthetase, glutamate reuptake, aspartate, excitatory amino acid transporters, vesicular glutamate transporters, glycine, D-serine, metabotropic and ionotropic glutamate receptors in the AD human brain (PROSPERO #CDRD42022299518). The studies were synthesized by outcome and brain region. We included cortical regions, the whole brain (cortical and subcortical regions combined), the entorhinal cortex and the hippocampus. Pooled effect sizes were determined with standardized mean differences (SMD), random effects adjusted by false discovery rate, and heterogeneity was examined by I2 statistics. The search retrieved 6 936 articles, 63 meeting the inclusion criteria (N = 709CN/786AD; mean age 75/79). We showed that the brain of AD individuals presents decreased glutamate (SMD = -0.82; I2 = 74.54%; P < 0.001) and aspartate levels (SMD = -0.64; I2 = 89.71%; P = 0.006), and reuptake (SMD = -0.75; I2 = 83.04%; P < 0.001. We also found reduced α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPAR)-GluA2/3 levels (SMD = -0.63; I2 = 95.55%; P = 0.046), hypofunctional N-methyl-D-aspartate receptor (NMDAR) (SMD = -0.60; I2 = 91.47%; P < 0.001) and selective reduction of NMDAR-GluN2B subunit levels (SMD = -1.07; I2 = 41.81%; P < 0.001). Regional differences include lower glutamate levels in cortical areas and aspartate levels in cortical areas and in the hippocampus, reduced glutamate reuptake, reduced AMPAR-GluA2/3 in the entorhinal cortex, hypofunction of NMDAR in cortical areas, and a decrease in NMDAR-GluN2B subunit levels in the entorhinal cortex and hippocampus. Other parameters studied were not altered. Our findings show depletion of the glutamatergic system and emphasize the importance of understanding glutamate-mediated neurotoxicity in AD. This study has implications for the development of therapies and biomarkers in AD.
Subject(s)
Alzheimer Disease , Brain , Glutamic Acid , Alzheimer Disease/metabolism , Humans , Glutamic Acid/metabolism , Brain/metabolism , Hippocampus/metabolism , Synaptic Transmission/physiology , Glutamine/metabolismABSTRACT
INTRODUCTION: The IMP is a novel video-based instrument to assess motor behavior of infants. It evaluates gross and fine motor behavior in five domains: variation, adaptability, symmetry, fluency, and performance. The latter assesses motor milestones, the other four domains assess qualitative aspects of movements. Literature suggests that it is a promising tool for pediatric health care, as its assists early detection of neurodevelopmental disorders and facilitates the design and monitoring of early intervention. This, this scoping review (ScR) aims to evaluate the psychometric properties of the Infant Motor Profile (IMP). MATERIAL AND METHODS: A systematic search will be conducted to identify relevant studies up to October 15, 2022. All papers published in English that evaluated or used the IMP in children under two years of age will be included. The search will be performed in Pubmed, Lilacs, PEDro, Scielo, CINAHL, Embase, Web of Science, Ovid PsycINFO, Cochrane Database of Systematic Reviews, as well as in gray literature sources following the University of Toronto library guidelines. Standardized data extraction forms (Excel Tables) will be used to collect information. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for the Scoping Reviews (PRISMA-ScR) Checklist and JBI guidelines will be taken into consideration for results analysis and reporting. DISCUSSION: This Scoping Review will summarize available knowledge on the psychometric properties of the IMP. By proving that IMP is a reliable tool, a valid predictor of neurodevelopmental outcomes and a responsive instrument to measure change induced by early intervention, this will facilitate the implementation of the IMP in pediatric health care. It will assist the detection of infants at high risk of neurodevelopmental disorders, and it will facilitate the design of the tailor-made early intervention. SCOPING REVIEW PROTOCOL REGISTRATION: This scoping review protocol has been registered at Open Science Framework (OSF) (https://doi.org/10.17605/OSF.IO/4HYKZ).
Subject(s)
Research Design , Humans , Infant , Early Diagnosis , Psychometrics , Systematic Reviews as TopicABSTRACT
PURPOSE: Advances in functional imaging allowed us to visualize brain glucose metabolism in vivo and non-invasively with [18F]fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) imaging. In the past decades, FDG-PET has been instrumental in the understanding of brain function in health and disease. The source of the FDG-PET signal has been attributed to neuronal uptake, with hypometabolism being considered as a direct index of neuronal dysfunction or death. However, other brain cells are also metabolically active, including astrocytes. Based on the astrocyte-neuron lactate shuttle hypothesis, the activation of the glutamate transporter 1 (GLT-1) acts as a trigger for glucose uptake by astrocytes. With this in mind, we investigated glucose utilization changes after pharmacologically downregulating GLT-1 with clozapine (CLO), an anti-psychotic drug. METHODS: Adult male Wistar rats (control, n = 14; CLO, n = 12) received CLO (25/35 mg kg-1) for 6 weeks. CLO effects were evaluated in vivo with FDG-PET and cortical tissue was used to evaluate glutamate uptake and GLT-1 and GLAST levels. CLO treatment effects were also assessed in cortical astrocyte cultures (glucose and glutamate uptake, GLT-1 and GLAST levels) and in cortical neuronal cultures (glucose uptake). RESULTS: CLO markedly reduced in vivo brain glucose metabolism in several brain areas, especially in the cortex. Ex vivo analyses demonstrated decreased cortical glutamate transport along with GLT-1 mRNA and protein downregulation. In astrocyte cultures, CLO decreased GLT-1 density as well as glutamate and glucose uptake. By contrast, in cortical neuronal cultures, CLO did not affect glucose uptake. CONCLUSION: This work provides in vivo demonstration that GLT-1 downregulation induces astrocyte-dependent cortical FDG-PET hypometabolism-mimicking the hypometabolic signature seen in people developing dementia-and adds further evidence that astrocytes are key contributors of the FDG-PET signal.
Subject(s)
Astrocytes , Clozapine , Animals , Clozapine/metabolism , Clozapine/pharmacology , Fluorodeoxyglucose F18/metabolism , Glucose/metabolism , Glutamic Acid/metabolism , Glutamic Acid/pharmacology , Humans , Male , Positron-Emission Tomography , Rats , Rats, WistarABSTRACT
Neonatal units should be organized as a progressive care line, with intermediate and intensive care beds (conventional and kangaroo). The aim of this study was to evaluate the status and adequacy of neonatal beds in maternity hospitals linked to the 'Stork Network' ("Rede Cegonha"). A descriptive study was conducted in 606 maternity hospitals in all regions of Brazil. The databases used belonged to the Stork Network Evaluation Survey and the National Live Birth System. To assess the distribution of neonatal beds by typology, the parameters proposed in Ordinance N. 930/2012 of the Ministry of Health were used. Most neonatal units are not organized as a progressive care line with the three types of bed planned. Kangaroo intermediate care beds comprise the minority of implanted beds. There is a concentration of intensive and intermediate beds in the Southeast and South regions, which show a kangaroo intermediate care bed deficit. Analyzing the adequacy of beds by the number of live births, one can observe an inadequacy of Kangaroo care beds in all regions of Brazil, as well as intensive bed deficit in the North and Northeast regions, and adequacy of conventional intermediate care beds in all regions.
As unidades neonatais devem ser organizadas como uma linha de cuidados progressivos com leitos de cuidado intensivo e intermediário (convencional e canguru). O objetivo deste estudo foi avaliar a situação e a adequação dos leitos neonatais em maternidades da Rede Cegonha. Estudo descritivo, realizado em 606 maternidades em todas as regiões do Brasil. Os bancos de dados utilizados foram os da Avaliação da Atenção ao Parto e Nascimento em Maternidades da Rede Cegonha e do Sistema Nacional de Nascidos Vivos. Para avaliar a distribuição de leitos neonatais por tipologia, foram utilizados os parâmetros propostos na Portaria GM/MS nº 930/2012. A minoria das unidades se organiza como uma linha de cuidados progressiva com as três tipologias de leito previstas (24,42%). Os leitos de cuidado intermediário Canguru são a minoria dos leitos implantados (11,27%). Há uma concentração de leitos intensivos e intermediários nas regiões Sudeste e Sul, que apresentam déficit de leitos de cuidado intermediário Canguru. Ao analisar a adequação dos leitos pelo número de nascidos vivos, verifica-se inadequação dos leitos de cuidado Canguru em todas as regiões do Brasil, déficit de leitos intensivos nas regiões Norte e Nordeste e adequação de leitos de cuidado intermediário convencional em todas as regiões.
Subject(s)
Hospitals, Maternity , Intensive Care Units, Neonatal , Brazil , Critical Care , Female , Humans , Infant, Newborn , Pregnancy , Surveys and QuestionnairesABSTRACT
Resumo As unidades neonatais devem ser organizadas como uma linha de cuidados progressivos com leitos de cuidado intensivo e intermediário (convencional e canguru). O objetivo deste estudo foi avaliar a situação e a adequação dos leitos neonatais em maternidades da Rede Cegonha. Estudo descritivo, realizado em 606 maternidades em todas as regiões do Brasil. Os bancos de dados utilizados foram os da Avaliação da Atenção ao Parto e Nascimento em Maternidades da Rede Cegonha e do Sistema Nacional de Nascidos Vivos. Para avaliar a distribuição de leitos neonatais por tipologia, foram utilizados os parâmetros propostos na Portaria GM/MS nº 930/2012. A minoria das unidades se organiza como uma linha de cuidados progressiva com as três tipologias de leito previstas (24,42%). Os leitos de cuidado intermediário Canguru são a minoria dos leitos implantados (11,27%). Há uma concentração de leitos intensivos e intermediários nas regiões Sudeste e Sul, que apresentam déficit de leitos de cuidado intermediário Canguru. Ao analisar a adequação dos leitos pelo número de nascidos vivos, verifica-se inadequação dos leitos de cuidado Canguru em todas as regiões do Brasil, déficit de leitos intensivos nas regiões Norte e Nordeste e adequação de leitos de cuidado intermediário convencional em todas as regiões.
Abstract Neonatal units should be organized as a progressive care line, with intermediate and intensive care beds (conventional and kangaroo). The aim of this study was to evaluate the status and adequacy of neonatal beds in maternity hospitals linked to the 'Stork Network' ("Rede Cegonha"). A descriptive study was conducted in 606 maternity hospitals in all regions of Brazil. The databases used belonged to the Stork Network Evaluation Survey and the National Live Birth System. To assess the distribution of neonatal beds by typology, the parameters proposed in Ordinance N. 930/2012 of the Ministry of Health were used. Most neonatal units are not organized as a progressive care line with the three types of bed planned. Kangaroo intermediate care beds comprise the minority of implanted beds. There is a concentration of intensive and intermediate beds in the Southeast and South regions, which show a kangaroo intermediate care bed deficit. Analyzing the adequacy of beds by the number of live births, one can observe an inadequacy of Kangaroo care beds in all regions of Brazil, as well as intensive bed deficit in the North and Northeast regions, and adequacy of conventional intermediate care beds in all regions.
Subject(s)
Humans , Female , Pregnancy , Infant, Newborn , Intensive Care Units, Neonatal , Hospitals, Maternity , Brazil , Surveys and Questionnaires , Critical CareSubject(s)
Carcinoma, Basal Cell/etiology , Carcinoma, Squamous Cell/etiology , Cicatrix, Hypertrophic/complications , Keloid/complications , Skin Neoplasms/etiology , Aged , Biopsy , Carcinoma, Basal Cell/pathology , Carcinoma, Squamous Cell/pathology , Cicatrix, Hypertrophic/pathology , Humans , Keloid/pathology , Male , Skin Neoplasms/pathologySubject(s)
Humans , Male , Aged , Skin Neoplasms/etiology , Carcinoma, Basal Cell/etiology , Carcinoma, Squamous Cell/etiology , Cicatrix, Hypertrophic/complications , Keloid/complications , Skin Neoplasms/pathology , Biopsy , Carcinoma, Basal Cell/pathology , Carcinoma, Squamous Cell/pathology , Cicatrix, Hypertrophic/pathology , Keloid/pathologyABSTRACT
A toxocaríase humana é uma infecção parasitária de distribuição mundial causada pelos nematelmintos das espécies Toxocara canis e Toxocara cati, presentes no intestino do cão e do gato, respectivamente. Clinicamente, na maioria das vezes, é assintomática, porém pode apresentar-se de duas formas: visceral ou ocular. Visceralmente, gera uma síndrome hipereosinofílica crônica, acompanhada por leucocitose e hepatomegalia, podendo ocorrer algum grau de infiltrado pulmonar e febre. Na toxocaríase ocular, ocorre uveite intermediária ou posterior, podendo haver formação de granuloma, geralmente unilateral. O acometimento misto é raro, o que motivou este relato. Trata-se de paciente de 19 anos, sexo masculino, que apresentou como sintoma inicial perda da acuidade visual em olho esquerdo. Recebeu tratamento, sem melhora, com sulfametoxazol + trimetoprima e corticoide, fazendo farmacodermia. Evoluiu com diarreia, febre, dor abdominal e hepatoesplenomegalia. Descartadas infecções agudas por toxoplasmose, sífilis, vírus da imunodeficiência humana (HIV), citomegalovirose e dengue; apresentou leucocitose com hipereosinofilia. Foi solicitada sorologia para toxocaríase, confirmando esta infecção. Após o tratamento, apresentou completa remissão dos sintomas. O objetivo aqui foi debater os fatores confundidores, diagnósticos diferenciais, necessidade de exames complementares específicos e conduta terapêutica, de acordo com o quadro clínico.(AU)
Human toxocariasis is a worldwide parasitic infection caused by ascarid nematodes species: Toxocara canis and Toxocara cati, that are present in the intestines of dogs and cats, respectively. Although clinically, most human infections are asymptomatic, two syndromes of human toxocariasis are recognized: visceral and ocular. The visceral form is a hypereosinophilic syndrome accompanied by leukocytosis, hepatomegaly, some degree of pulmonary infiltrate and fever. In ocular toxacariasis there is intermediate or posterior uveitis, and there may be granuloma formation, usually unilateral. The simultaneous involvement of the two forms is rare, which is what, motivated this report. It is a 19-year-old male patient who initially presented loss of visual acuity in the left eye. He received treatment, without improvement, with sulfamethoxazole-trimethoprim and corticoid, causing a pharmacodermia. He developed diarrhea, fever, abdominal pain and hepatosplenomegaly. It was discarded acute infections by toxoplasmosis, syphilis, human immunodeficiency virus (HIV), cytomegalovirus and dengue. The patient also manifested leukocytosis with hypereosinophilia. Serological testing for toxacariasis was requested, diagnosing the infection. After treatment, he progressed with full symptoms remission. The aim of this study was to discuss confounding factors, differential diagnoses, the need for specific complementary exams and therapeutic management, according to the clinical aspects.(AU)